Table 3. Clinical characteristics and baseline demographics of schizophrenia patients treated with risperidone.
Features | Total (n = 130) | Male (n = 45) | Female (n = 85) | p value |
Age (years) | 36.3±11.2 | 35.9±12.8 | 36.4±10.4 | 0.798 |
Age of onset (years) | 30.3±10.3 | 28.4±10.6 | 31.3±10.1 | 0.132 |
Plasma risperidone levels (ng/ml) | 7.6±6.3 | 7.0±6.4 | 7.9±6.3 | 0.469 |
Plasma 9-hydrorisperidone levels (ng/ml) | 23.4±16.2 | 23.9±21.1 | 23.1±13.2 | 0.789 |
Baseline Prolactin (mIU/L) | 775.2±733.8 | 508.0±340.2 | 907.2±835.5 | 0.004* |
Baseline BPRS score | 42.4±12.4 | 42.2±12.6 | 42.5±12.3 | 0.879 |
Data are shown as mean±SD. BPRS: Brief Psychiatric Rating Scale. *Significant difference (p<0.05) between males and females.